RICT 2008 - Drug Discovery and Selection
Biophysics Tools and ADME Tox
03/07/2009
14:00
Biophysical Approaches in the Hit-to-Lead Optimisation Strategy
Dr. Jean BOUTIN
(INSTITUT DE RECHERCHES SERVIER, Croissy-sur-Seine, France)
03/07/2009
14:45
ADME-PK Optimization Strategies in Drug Discovery and Selection
Dr. Sonia POLI
(ADDEX PHARMA, Plan-les-Ouates, Switzerland)
From Target Identification to Development
01/07/2009
11:00
The Therapeutic Potential of Pharmacological Inhibitors of Cyclin-Dependent Kinases
Dr Laurent MEIJER
(CNRS - ROSCOFF, Roscoff, France)
01/07/2009
11:45
Targeted Small Molecule Anti-Cancer Drugs: an Asian Perspective from Discovery to Clinical
Dr. Stéphanie BLANCHARD
(S*BIO, Singapore, Singapore)
01/07/2009
14:30
Selective Inhibitors of MMP-12 : from Chemistry to Therapeutic Applications
Dr. Vincent DIVE
(CEA, Gif-sur-Yvette, France)
01/07/2009
15:15
Discovery of the Macrocyclic HCV Protease Inhibitor TMC435350
Dr Pierre RABOISSON
(JANSSEN PHARMACEUTICAL COMPANIES, Beerse, Belgium)
01/07/2009
16:30
Irreversible Serine Protease Inhibitors: Useful Tools in Drug Discovery
Prof. Koen AUGUSTYNS
(UNIVERSITY OF ANTWERP, Antwerp, Belgium)
01/07/2009
17:15
« Paul Ehrlich» Lecture: Discovery of Xarelto, a Novel, Oral Antithrombotic Agent
Dr. Susanne ROEHRIG
(BAYER SCHERING PHARMA, Wuppertal, Germany)
High Throughput Screening and Lead Identification
02/07/2009
14:00
Generation of New Active Compounds in an Industrial-Academic Screening Organization
Dr. Frederic AUSSEIL
(INSTITUT DE RECHERCHE PIERRE FABRE, Toulouse, France)
02/07/2009
14:45
New Strategies in Chemical Biology : Scientific and Therapeutic Outcome
Prof. Marcel HIBERT
(UNIVERSITY OF STRASBOURG, Illkirch, France)
02/07/2009
15:30
The Crystal Structure of the Adenosine A2A Receptor - Implications for GPCR Drug Design
Prof. Ad P. IJZERMAN
(UNIVERSITY OF LEIDEN, Leiden, The Netherlands)
02/07/2009
17:00
Aptamers: Oligonucleotides that Rival Antibodies for Therapeutics and Diagnostics.
Prof. Jean-Jacques TOULME
(IECB & INSERM - UNIVERSITÉ BORDEAUX II, Bordeaux, France)
02/07/2009
17:45
Recent Developments in Structural Biology: Applying Crystallographic and NMR Approaches in Lead Finding and Optimization
Dr Vincent MIKOL
(SANOFI AVENTIS, Vitry-sur-Seine, France)
Imaging
02/07/2009
08:30
Facilitating Drug Development with PET Imaging
Dr Yves P. AUBERSON
(, Basel, Switzerland)
02/07/2009
09:15
Targeting G-Protein Coupled Receptors with Radiolabeled Peptides for the Molecular Imaging and Targeted Therapy of Cancer
Dr. Helmut MAECKE
(UNIVERSITY HOSPITAL, Basel, Switzerland)
02/07/2009
10:30
PET Imaging in Drug Discovery and Development of CNS Drugs
Dr. Jose Ignacio ANDRES
(JOHNSON & JOHNSON PHARMACEUTICAL R & D, Toledo, Spain)
02/07/2009
11:15
Modified Selective Integrin Ligands for Cancer Therapy, Molecular Imaging and for Improvement of Biomaterials
Dr Horst KESSLER
(TECHNISCHE UNIVERSITÄT MÜNCHEN, Garching, Germany)
In Silico Selection
01/07/2009
09:30
Navigation in Chemistry Universe Towards Biological Activity
Dr Peter ERTL
(NOVARTIS INSTITUTE FOR BIOMEDICAL RESEARCH, Basel, Switzerland)
01/07/2009
10:15
Structure-Based in Silico Screening: Free Tools and Applications
Dr. Bruno VILLOUTREIX
(INSERM - UNIVERSITY PARIS DIDEROT, Paris, France)
Interfacing Chembio and MedChem
02/07/2009
08:30
GLP-1 Analog Taspoglutide: Design, Synthesis and Biological Activity
Dr. Jesse DONG
(IPSEN, Milford, United States)
02/07/2009
09:15
Experiences in Fragment Based Lead Discovery
Prof. Rod HUBBARD
(UNIVERSITY OF YORK / VERNALIS, York, United Kingdom)
02/07/2009
10:30
Using Knowledge from NBEs to Inform Drug Design
Dr. Alastair LAWSON
(UCB CELLTECH, Slough, United Kingdom)
02/07/2009
11:15
Diversity Oriented Synthesis of Natural Product Motifs
Prof. Nicolas WINSSINGER
(UNIVERSITY OF STRASBOURG, Strasbourg, France)
Synthesis and Lead Optimization
02/07/2009
14:00
Discovery of Potent, Selective and Orally Bioavailable DP2 Receptor Antagonists for the Treatment of Allergic Inflammatory Diseases
Dr. Stefano CROSIGNANI
(MERCK-SERONO PHARMACEUTICAL RESEARCH INSTITUTE, Plan-les-Ouates, Switzerland)
02/07/2009
14:45
Dynamic Combinatorial Chemistry in Chemical Biology and Drug Discovery
Prof. Jean-Marie BEAU
(UNIVERSITÉ PARIS SUD 11, Orsay, France)
02/07/2009
15:30
Development of Marine Anticancer Drugs
Dr. Andrès FRANCESCH
(PHARMAMAR, Colmenar Viejo, Spain)
02/07/2009
17:00
A Chemistry-Driven Approach to the Discovery of New Calcium-Sensing Receptor Ligands and Antimitotic Agents
Dr. Robert H. DODD
(ICSN CNRS, Gif-Sur-Yvette, France)
02/07/2009
17:45
Knowledge management, prospective design and chemical enablement as strategies for lead optimization: The PDE-9 inhibitor and opiate antagonist case studies.
Dr. Spiros LIRAS
(PFIZER GLOBAL RESEARCH, Groton, United States)
03/07/2009
09:00
Taking up the Adme Challenge
Prof. Benoit DEPREZ
(UNIVERSITY OF LILLE 2, Lille, France)
03/07/2009
09:45
Discovery of Novel Potent, Selective and Orally Efficacious A2B Adenosine Receptor Antagonists.
Dr. Bernat VIDAL
(LABORATORIOS ALMIRALL, Barcelona, Spain)
03/07/2009
11:00
New Synthetic Methods and their Application to the Preparation of Biologically Active Molecules
Prof. Mike SHIPMAN
(UNIVERSITY OF WARWICK, Coventry, United Kingdom)
03/07/2009
11:45
« Prix Charles Mentzer »: From Heparin to New Anticoagulants with Unprecedented Pharmacological Profile
Dr. Maurice PETITOU
(ENDOTIS PHARMA, Romainville, France)
<Previous page


Sponsors

Exhibitors

Media Partner